Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Impact of Multiple Minor Histocompatibility Antigen Differences on Graft-Versus-Host Disease and Relapse Risk in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients

Christian Mueller, Malik Alawi, Juergen Loeffler, Michael Bonin, Andreas Schreiber, Hermann Kreyenberg, Verena Wiegering, Matthias Woelfl, Ignazio Caruana, Paul G. Schlegel, Matthias Eyrich

Blood (2023) 142 (Supplement 1): 7106.

https://doi.org/10.1182/blood-2023-188511

Published: 2023

Journal Articles

Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies

Blood (2018) 132 (Supplement 1): 3354.

https://doi.org/10.1182/blood-2018-99-110980

Published: 2018

Journal Articles

Children and Adults with Steroid-Refractory Acute Graft-Versus-Host Disease Respond to Treatment with the Mesenchymal Stroma Cell Preparation "MSC-FFM": Treatment Results for 92 Consecutive Patients

Blood (2018) 132 (Supplement 1): 603.

https://doi.org/10.1182/blood-2018-99-110599

Published: 2018

Journal Articles

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

Blood (2018) 132 (Supplement 1): 604.

https://doi.org/10.1182/blood-2018-99-110124

Published: 2018

Journal Articles

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 599.

https://doi.org/10.1182/blood.V130.Suppl_1.599.599

Published: 2017

Journal Articles

Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial

Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD PhD, Sandra Karitzky, PhD, Silke Holtkamp, Christiane Siewert, PhD, Stefanie Pflitsch, Michael Schumm, DVM, Matthias K. Eyrich, MD, Markus Wiesneth, MD, Halvard Bonig, MD MA, Rupert Handgretinger, MD PhD

Blood (2017) 130 (Supplement 1): 214.

https://doi.org/10.1182/blood.V130.Suppl_1.214.214

Published: 2017

Journal Articles

TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: First Results of a Prospective Multicenter Phase I/II Clinical Trial

Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD, Sandra Karitzky, PhD, Silke Holtkamp, PhD, Christiane Siewert, PhD, Michael Schumm, VMD, Matthias K. Eyrich, MD, Markus Wiesneth, Halvard Bönig, MD, Rupert Handgretinger, MD

Blood (2016) 128 (22): 389.

https://doi.org/10.1182/blood.V128.22.389.389

Published: 2016

Journal Articles

Decentralized Manufacture of TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Grafts for Children within a Multicenter Phase I/II Clinical Trial

Michael Schumm, VMD, Matthias K. Eyrich, MD, Markus Wiesneth, Halvard Bönig, MD, Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD, Murat Aktas, Philipp Dresing, PhD, Sandra Karitzky, PhD, Silke Holtkamp, PhD, Rupert Handgretinger, MD

Blood (2016) 128 (22): 2172.

https://doi.org/10.1182/blood.V128.22.2172.2172

Published: 2016

Journal Articles

CD40-Licensing Of Human Dendritic Cells Further Matures Tnfa-Treated Dcs But Does Not Mediate Resistance Against Inhibition Of T-Cell Proliferation By T REG

Matthias Eyrich, PhD, MD, Johannes Rachor, Marissa Blume, Isabelle Becker, Anne Stumpf, Harald Wajant, PhD, Matthias Wolfl, MD, Paul G. Schlegel, MD, Manfred Lutz, PhD

Blood (2013) 122 (21): 4726.

https://doi.org/10.1182/blood.V122.21.4726.4726

Published: 2013

Journal Articles

Impact Of Prophylaxis With Defibrotide On The Occurrence Of Acute GvHD In Allogeneic HSCT

Blood (2013) 122 (21): 4591.

https://doi.org/10.1182/blood.V122.21.4591.4591

Published: 2013

Journal Articles

Clinical Impact Of Post-Transplant Chimerism Monitoring In CD33/34 Bone Marrow Subpopulations and Whole Blood In Pediatric AML: Prospective Comparison Of Highly Sensitive Real Time Sequence Polymorphism PCR Versus Gold-Standard Conventional STR-PCR

Andre Manfred Willasch, MD, Eva Rettinger, MD, Marion Zabel, MD, Hermann Kreyenberg, PhD, Vida Meyer, Arndt Borkhardt, MD, Markus Metzler, MD, Bernhard Kremens, MD, Brigitte Strahm, MD, Wilhelm Woessmann, MD, Christine Mauz-Koerholz, MD, Bernd Gruhn, Stefan Burdach, MD, Michael H Albert, MD, Paul G. Schlegel, MD, Thomas Klingebiel, MD, Peter Bader

Blood (2013) 122 (21): 411.

https://doi.org/10.1182/blood.V122.21.411.411

Published: 2013

Journal Articles

Src-kinase inhibitors sensitize human cells of myeloid origin to Toll-like-receptor–induced interleukin 12 synthesis

Matthias Wölfl, Stefanie Schwinn, Young-Eun Yoo, Marie L. Reß, Matthias Braun, Martin Chopra, Susanne C. Schreiber, Victor I. Ayala, Claes Ohlen, Matthias Eyrich, Andreas Beilhack, Paul G. Schlegel

Blood (2013) 122 (7): 1203–1213.

https://doi.org/10.1182/blood-2013-03-488072

Published: 2013

Includes: Supplemental data

Journal Articles

NK Cell Activity Influences Long Term Outcome of Pediatric Leucemias After T Cell Depleted Stem Cell Transplantation,

Peter Lang, MD, Matthias Pfeiffer, MD, Heiko-Manuel Teltschik, MD, Paul G. Schlegel, MD, Tobias F. Feuchtinger, MD, Thomas Klingebiel, MD, James F. Beck, MD, Rupert Handgretinger, MD

Blood (2011) 118 (21): 4141.

https://doi.org/10.1182/blood.V118.21.4141.4141

Published: 2011

Journal Articles

Interference with Inflammation Induced Endothelial Receptors Prevents Acute Graft-Versus-Host Disease.

Andreas Beilhack, MD, Jeanette Baker, Christian Brede, Simone S Riedel, Carina A Baeuerlein, Carolin Kiesel, Ana-Laura Jordan Garrote, Rossella Monteforte, PhD, Miriam Ritz, Marina Grether, Georg F Beilhack, MD, Paul G. Schlegel, MD, Hermann Einsele, MD, Robert Negrin, MD, Stephan Schulz, MD

Blood (2009) 114 (22): 3559.

https://doi.org/10.1182/blood.V114.22.3559.3559

Published: 2009

Journal Articles

Retransplantation with Stem Cells from Mismatched Related Donors after Graft Rejection in Pediatric Patients.

Peter J. Lang, MD, Johann Greil, MD, Ingo Müller, MD, Peter Bader, MD, Thomas Klingebiel, MD, Frank Heinzelmann, MD, Claus Belka, MD, Bernhard Kremens, MD, Alfred Reiter, MD, Paul G. Schlegel, MD, Rupert Handgretinger, MD

Blood (2006) 108 (11): 2955.

https://doi.org/10.1182/blood.V108.11.2955.2955

Published: 2006

Journal Articles

Differences in Immune Reconstitution and Cytokine Production in Children with Sibling Donor BMT Versus T-Cell Depleted PBSCT from Unrelated or Mismatched Family Donors.

Verena A. Wiegering, Matthias Eyrich, Paul G. Schlegel, Beate Winkler

Blood (2006) 108 (11): 2916.

https://doi.org/10.1182/blood.V108.11.2916.2916

Published: 2006

Journal Articles

Changes in the Immune Functions during ALL Induction Therapy - Prospective Immune Monitoring in 23 Children.

Verena A. Wiegering, Matthias Eyrich, Paul G. Schlegel, Beate Winkler

Blood (2006) 108 (11): 4519.

https://doi.org/10.1182/blood.V108.11.4519.4519

Published: 2006

Journal Articles

Improved Immune Reconstitution with Low Incidence of Severe Graft-Versus-Host Disease after Transplantation of CD34 + or CD133 + Enriched Stem Cells with Add-Back of Ten Million T-Cells Per Kg.

Johann Greil, M.D., Peter Lang, M.D., Peter Bader, M.D., Matthias Eyrich, M.D., Paul G. Schlegel, M.D., Michael Schumm, M.D., Tobias Feuchtinger, M.D., Dietrich Niethammer, M.D.

Blood (2004) 104 (11): 1239.

https://doi.org/10.1182/blood.V104.11.1239.1239

Published: 2004

Journal Articles

Transplantation of highly purified CD34 + progenitor cells from unrelated donors in pediatric leukemia

Peter Lang, Rupert Handgretinger, Dietrich Niethammer, Paul G. Schlegel, Michael Schumm, Johann Greil, Peter Bader, Corinna Engel, Hans Scheel-Walter, Matthias Eyrich, Thomas Klingebiel

Blood (2003) 101 (4): 1630–1636.

https://doi.org/10.1182/blood-2002-04-1203

Published: 2003

Journal Articles

Identification of a novel class of human adherent CD34 − stem cells that give rise to SCID-repopulating cells

Selim Kuçi, Johannes T. Wessels, Hans-Jörg Bühring, Karin Schilbach, Michael Schumm, Gabriele Seitz, Jürgen Löffler, Peter Bader, Paul G. Schlegel, Dietrich Niethammer, Rupert Handgretinger

Blood (2003) 101 (3): 869–876.

https://doi.org/10.1182/blood-2002-03-0711

Published: 2003

NARROW

Impact of Multiple Minor Histocompatibility Antigen Differences on Graft-Versus-Host Disease and Relapse Risk in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients

Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies

Children and Adults with Steroid-Refractory Acute Graft-Versus-Host Disease Respond to Treatment with the Mesenchymal Stroma Cell Preparation "MSC-FFM": Treatment Results for 92 Consecutive Patients

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial

TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: First Results of a Prospective Multicenter Phase I/II Clinical Trial

Decentralized Manufacture of TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Grafts for Children within a Multicenter Phase I/II Clinical Trial

CD40-Licensing Of Human Dendritic Cells Further Matures Tnfa-Treated Dcs But Does Not Mediate Resistance Against Inhibition Of T-Cell Proliferation By T REG

Impact Of Prophylaxis With Defibrotide On The Occurrence Of Acute GvHD In Allogeneic HSCT

Clinical Impact Of Post-Transplant Chimerism Monitoring In CD33/34 Bone Marrow Subpopulations and Whole Blood In Pediatric AML: Prospective Comparison Of Highly Sensitive Real Time Sequence Polymorphism PCR Versus Gold-Standard Conventional STR-PCR

Src-kinase inhibitors sensitize human cells of myeloid origin to Toll-like-receptor–induced interleukin 12 synthesis

NK Cell Activity Influences Long Term Outcome of Pediatric Leucemias After T Cell Depleted Stem Cell Transplantation,

Interference with Inflammation Induced Endothelial Receptors Prevents Acute Graft-Versus-Host Disease.

Retransplantation with Stem Cells from Mismatched Related Donors after Graft Rejection in Pediatric Patients.

Differences in Immune Reconstitution and Cytokine Production in Children with Sibling Donor BMT Versus T-Cell Depleted PBSCT from Unrelated or Mismatched Family Donors.

Changes in the Immune Functions during ALL Induction Therapy - Prospective Immune Monitoring in 23 Children.

Improved Immune Reconstitution with Low Incidence of Severe Graft-Versus-Host Disease after Transplantation of CD34 + or CD133 + Enriched Stem Cells with Add-Back of Ten Million T-Cells Per Kg.

Transplantation of highly purified CD34 + progenitor cells from unrelated donors in pediatric leukemia

Identification of a novel class of human adherent CD34 − stem cells that give rise to SCID-repopulating cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only